Early research (Phase 1)Ended earlyNCT04446000
What this trial is testing
Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CSL730 in Healthy Adult Subjects
Who this might be right for
Immune Complex-mediated Autoimmune Diseases
CSL Behring 52